Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

EUCRU - Eucrates Biomedical Acquisition Corp - Units (1 Ord & 1/3 War)


Previous close
10.02
0   0%

Share volume: 21,513
Last Updated: Wed 26 Apr 2023 06:00:00 AM CEST

PREVIOUS CLOSE
CHG
CHG%

$10.02
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$10.02
P/E Ratio 
0.00
DAY RANGE
$10.01 - $10.02
EPS 
$0.00
52 WEEK RANGE
$0.00 - $0.00
52 WEEK CHANGE
$0.00
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
10.350 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$0
AVERAGE 30 VOLUME 
$0
Company detail
CEO:
Region: US
Website:
Employees: 4
IPO year: -
Issue type:
Market: XNAS
Industry:
Sector:

Eucrates Biomedical Acquisition Corp. is a special purpose acquisition company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. While the Company may pursue an initial business combination target in any business or industry, it intends to focus on the biomedical and healthcare industry. The Company intends to target North American and European healthcare companies with the potential to drive transformational change through the convergence of biomedicine and data science. "Eucrates" is a portmanteau, formed by combining Euclid (the Father of Geometry) and Hippocrates (the Father of Medicine).

Recent news